Rates and risk factors for preterm birth and low birthweight in the global network sites in six low- and low middle-income countries.
Africa
Global network
Guatemala
India
Low and middle-income countries
Low birth weight
Preterm
Risk factors
Journal
Reproductive health
ISSN: 1742-4755
Titre abrégé: Reprod Health
Pays: England
ID NLM: 101224380
Informations de publication
Date de publication:
17 Dec 2020
17 Dec 2020
Historique:
received:
23
10
2020
accepted:
29
10
2020
entrez:
18
12
2020
pubmed:
19
12
2020
medline:
16
6
2021
Statut:
epublish
Résumé
Preterm birth continues to be a major public health problem contributing to 75% of the neonatal mortality worldwide. Low birth weight (LBW) is an important but imperfect surrogate for prematurity when accurate assessment of gestational age is not possible. While there is overlap between preterm birth and LBW newborns, those that are both premature and LBW are at the highest risk of adverse neonatal outcomes. Understanding the epidemiology of preterm birth and LBW is important for prevention and improved care for at risk newborns, but in many countries, data are sparse and incomplete. We conducted data analyses using the Global Network's (GN) population-based registry of pregnant women and their babies in rural communities in six low- and middle-income countries (Democratic Republic of Congo, Kenya, Zambia, Guatemala, India and Pakistan). We analyzed data from January 2014 to December 2018. Trained study staff enrolled all pregnant women in the study catchment area as early as possible during pregnancy and conducted follow-up visits shortly after delivery and at 42 days after delivery. We analyzed the rates of preterm birth, LBW and the combination of preterm birth and LBW and studied risk factors associated with these outcomes across the GN sites. A total of 272,192 live births were included in the analysis. The overall preterm birth rate was 12.6% (ranging from 8.6% in Belagavi, India to 21.8% in the Pakistani site). The overall LBW rate was 13.6% (ranging from 2.7% in the Kenyan site to 21.4% in the Pakistani site). The overall rate of both preterm birth and LBW was 5.5% (ranging from 1.2% in the Kenyan site to 11.0% in the Pakistani site). Risk factors associated with preterm birth, LBW and the combination were similar across sites and included nulliparity [RR - 1.27 (95% CI 1.21-1.33)], maternal age under 20 [RR 1.41 (95% CI 1.32-1.49)] years, severe antenatal hemorrhage [RR 5.18 95% CI 4.44-6.04)], hypertensive disorders [RR 2.74 (95% CI - 1.21-1.33], and 1-3 antenatal visits versus four or more [RR 1.68 (95% CI 1.55-1.83)]. Preterm birth, LBW and their combination continue to be common public health problems at some of the GN sites, particularly among young, nulliparous women who have received limited antenatal care services. Trial registration The identifier of the Maternal and Newborn Health Registry at ClinicalTrials.gov is NCT01073475. The identifier of the Maternal and Newborn Health Registry at ClinicalTrials.gov is NCT01073475.
Sections du résumé
BACKGROUND
BACKGROUND
Preterm birth continues to be a major public health problem contributing to 75% of the neonatal mortality worldwide. Low birth weight (LBW) is an important but imperfect surrogate for prematurity when accurate assessment of gestational age is not possible. While there is overlap between preterm birth and LBW newborns, those that are both premature and LBW are at the highest risk of adverse neonatal outcomes. Understanding the epidemiology of preterm birth and LBW is important for prevention and improved care for at risk newborns, but in many countries, data are sparse and incomplete.
METHODS
METHODS
We conducted data analyses using the Global Network's (GN) population-based registry of pregnant women and their babies in rural communities in six low- and middle-income countries (Democratic Republic of Congo, Kenya, Zambia, Guatemala, India and Pakistan). We analyzed data from January 2014 to December 2018. Trained study staff enrolled all pregnant women in the study catchment area as early as possible during pregnancy and conducted follow-up visits shortly after delivery and at 42 days after delivery. We analyzed the rates of preterm birth, LBW and the combination of preterm birth and LBW and studied risk factors associated with these outcomes across the GN sites.
RESULTS
RESULTS
A total of 272,192 live births were included in the analysis. The overall preterm birth rate was 12.6% (ranging from 8.6% in Belagavi, India to 21.8% in the Pakistani site). The overall LBW rate was 13.6% (ranging from 2.7% in the Kenyan site to 21.4% in the Pakistani site). The overall rate of both preterm birth and LBW was 5.5% (ranging from 1.2% in the Kenyan site to 11.0% in the Pakistani site). Risk factors associated with preterm birth, LBW and the combination were similar across sites and included nulliparity [RR - 1.27 (95% CI 1.21-1.33)], maternal age under 20 [RR 1.41 (95% CI 1.32-1.49)] years, severe antenatal hemorrhage [RR 5.18 95% CI 4.44-6.04)], hypertensive disorders [RR 2.74 (95% CI - 1.21-1.33], and 1-3 antenatal visits versus four or more [RR 1.68 (95% CI 1.55-1.83)].
CONCLUSIONS
CONCLUSIONS
Preterm birth, LBW and their combination continue to be common public health problems at some of the GN sites, particularly among young, nulliparous women who have received limited antenatal care services. Trial registration The identifier of the Maternal and Newborn Health Registry at ClinicalTrials.gov is NCT01073475.
TRIAL REGISTRATION
BACKGROUND
The identifier of the Maternal and Newborn Health Registry at ClinicalTrials.gov is NCT01073475.
Identifiants
pubmed: 33334356
doi: 10.1186/s12978-020-01029-z
pii: 10.1186/s12978-020-01029-z
pmc: PMC7745351
doi:
Banques de données
ClinicalTrials.gov
['NCT01073475']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
187Subventions
Organisme : NICHD NIH HHS
ID : UG1 HD076461
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD078439
Pays : United States
Organisme : NICHD NIH HHS
ID : U10 HD076465
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD076465
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD078438
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD076457
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD076474
Pays : United States
Références
J Pak Med Assoc. 2013 Mar;63(3):414-8
pubmed: 23914656
Hong Kong Med J. 2002 Jun;8(3):163-6
pubmed: 12055359
Lancet Glob Health. 2019 Jan;7(1):e37-e46
pubmed: 30389451
BJOG. 2018 Nov;125(12):1591-1599
pubmed: 29782696
BMC Pregnancy Childbirth. 2017 May 3;17(1):135
pubmed: 28468653
BMC Pregnancy Childbirth. 2016 Nov 22;16(1):365
pubmed: 27876014
Lancet Glob Health. 2019 Jul;7(7):e849-e860
pubmed: 31103470
Am J Epidemiol. 2012 Sep 1;176(5):443-55
pubmed: 22886591
Lancet. 2014 Sep 6;384(9946):869-79
pubmed: 25209488
Obstet Gynecol. 2017 May;129(5):e150-e154
pubmed: 28426621
Am J Perinatol. 2013 Oct;30(9):787-94
pubmed: 23329566
Int J Med Sci. 2013 Sep 24;10(12):1683-8
pubmed: 24151440
BMC Pregnancy Childbirth. 2014 Mar 20;14:111
pubmed: 24650219
Lancet. 2011 May 28;377(9780):1855-61
pubmed: 21621717
N Engl J Med. 2017 Aug 17;377(7):613-622
pubmed: 28657417
Obesity (Silver Spring). 2016 Jan;24(1):215-22
pubmed: 26574712
Niger J Clin Pract. 2015 Nov-Dec;18(6):744-50
pubmed: 26289511
BMJ Open. 2018 Aug 8;8(8):e021623
pubmed: 30093518
J Pediatr (Rio J). 2012 May;88(3):259-66
pubmed: 22717575
Reprod Health. 2020 Nov 30;17(Suppl 2):159
pubmed: 33256778
BJOG. 2019 May;126(6):737-743
pubmed: 30554474
Lancet Glob Health. 2013 Jul;1(1):e26-36
pubmed: 25103583
PLoS Med. 2012;9(8):e1001292
pubmed: 22904691
Reprod Health. 2016 May 24;13(1):62
pubmed: 27220987
Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):372-6
pubmed: 23928480
Am J Perinatol. 2018 Jul;35(9):844-851
pubmed: 29365329
Lancet. 2013 Aug 3;382(9890):417-425
pubmed: 23746775
Hum Reprod. 2002 Oct;17(10):2762-8
pubmed: 12351559
Reprod Health. 2013;10 Suppl 1:S2
pubmed: 24625129
BMC Health Serv Res. 2017 May 19;17(1):360
pubmed: 28526027
Lancet. 2015 Feb 14;385(9968):629-639
pubmed: 25458726
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Lancet. 2014 Sep 6;384(9946):857-68
pubmed: 25209487
Semin Perinatol. 2017 Nov;41(7):387-391
pubmed: 28865982
J Pediatr. 2018 Jan;192:66-72.e4
pubmed: 29246361
Int J Gynaecol Obstet. 2012 Sep;118(3):190-3
pubmed: 22738806
PLoS One. 2015 May 29;10(5):e0127890
pubmed: 26024473
BMC Pediatr. 2012 Feb 22;12:17
pubmed: 22356724
BMC Med. 2014 Nov 27;12:220
pubmed: 25428603
Reprod Health. 2015;12 Suppl 2:S1
pubmed: 26063166
Pan Afr Med J. 2015 Feb 05;20:108
pubmed: 26090056